These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18422448)

  • 1. Polymorphic and conserved targets of antibodies against Plasmodium falciparum during pregnancy.
    Beeson JG; Elliott SR; Hommel M
    J Infect Dis; 2008 May; 197(9):1350-1; author reply 1351-2. PubMed ID: 18422448
    [No Abstract]   [Full Text] [Related]  

  • 2. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites.
    Ntumngia FB; Bouyou-Akotet MK; Uhlemann AC; Mordmüller B; Kremsner PG; Kun JF
    Mol Biochem Parasitol; 2004 Oct; 137(2):349-53. PubMed ID: 15383306
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy.
    Fievet N; Le Hesran JY; Cottrell G; Doucoure S; Diouf I; Ndiaye JL; Bertin G; Gaye O; Sow S; Deloron P
    Infect Genet Evol; 2006 Nov; 6(6):459-63. PubMed ID: 16621725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune response against Plasmodium falciparum merozoite antigens and HLA restriction].
    Dieye A; Sarthou JL
    Med Trop (Mars); 1995; 55(4 Suppl):69-70. PubMed ID: 8649270
    [No Abstract]   [Full Text] [Related]  

  • 6. The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective.
    Hviid L
    Parasite Immunol; 2004; 26(11-12):477-86. PubMed ID: 15771683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity.
    Bull PC; Pain A; Ndungu FM; Kinyanjui SM; Roberts DJ; Newbold CI; Marsh K
    J Infect Dis; 2005 Sep; 192(6):1119-26. PubMed ID: 16107968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinating with the genome: a Sisyphean task?
    Coppel RL
    Trends Parasitol; 2009 May; 25(5):205-12. PubMed ID: 19359219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
    Iriemenam NC; Khirelsied AH; Nasr A; ElGhazali G; Giha HA; Elhassan A-Elgadir TM; Agab-Aldour AA; Montgomery SM; Anders RF; Theisen M; Troye-Blomberg M; Elbashir MI; Berzins K
    Vaccine; 2009 Jan; 27(1):62-71. PubMed ID: 18977268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
    Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
    Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral T-cell non-responsiveness in individuals exposed to Plasmodium falciparum malaria.
    Hviid L
    APMIS Suppl; 1995; 53():1-46. PubMed ID: 9409941
    [No Abstract]   [Full Text] [Related]  

  • 13. Human antibody subclass ELISA.
    Druilhe P; Bouharoun-Tayoun H
    Methods Mol Med; 2002; 72():457-9. PubMed ID: 12125141
    [No Abstract]   [Full Text] [Related]  

  • 14. Targets of protective antibodies to malaria during pregnancy.
    Beeson JG; Rogerson SJ; Elliott SR; Duffy MF
    J Infect Dis; 2005 Nov; 192(9):1647-50. PubMed ID: 16206081
    [No Abstract]   [Full Text] [Related]  

  • 15. Theoretical immunology: parasitic turncoat.
    Antia R; Koella J
    Nature; 2004 Jun; 429(6991):511-3. PubMed ID: 15175734
    [No Abstract]   [Full Text] [Related]  

  • 16. PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum.
    Pasternak ND; Dzikowski R
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1463-6. PubMed ID: 19150410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hope but challenge for developing a vaccine that might control malaria.
    Good MF
    Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The varieties of gene amplification, diversification and hypervariability in the human malaria parasite, Plasmodium falciparum.
    Templeton TJ
    Mol Biochem Parasitol; 2009 Aug; 166(2):109-16. PubMed ID: 19375460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens.
    Oleinikov AV; Rossnagle E; Francis S; Mutabingwa TK; Fried M; Duffy PE
    J Infect Dis; 2007 Jul; 196(1):155-64. PubMed ID: 17538896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice.
    Martínez PA; Yandar N; Lesmes LP; Forero M; Pérez-Leal O; Patarroyo ME; Lozano JM
    Peptides; 2009 Feb; 30(2):330-42. PubMed ID: 19071172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.